Inflammatory Bowel Disease (IBD) consists of two chronic, immune-mediated conditions affecting the intestine: Crohn's disease (CD) and Ulcerative Colitis (UC). Patients suffering from these conditions often require multi-disciplinary management. In the past 20 years the approach to IBD has changed, mainly with the introduction of new therapeutic agents and the emerging role of surgery. Advances in our understanding of the disease, diagnostic tools and surgical equipment have led to improved treatment outcomes and controversial issues. In the next coming years, efforts will focus on improved peri-operative management, prevention of disease recurrence after surgery, and quality of life improvement.
The aim of this special issue is to summarize advances and controversies in the surgical treatment of Inflammatory Bowel Disease, and to point out areas for further research.
We welcome submissions on the following topics (but are not limited to):
- Advantages and disadvantages of two-stage pouch procedures versus three-stage operations in different clinical scenarios for patients with ulcerative colitis.
- Bariatric surgery in IBD patients.
- Proctologic procedures in IBD patients.
- Surgical management of perianal active Crohn's disease.
- Ileal Pouch Anal Anastomosis in patients with Crohn's disease.
- Novel types of anastomosis (i.e. Kono-S).
- Challenges in managing immunosuppression therapy in steroids dependent patients during the perioperative period, specifically examining if active disease or active immunosuppression has a greater impact on outcomes.
- Need for total proctocolectomy for all UC patients with low-grade dysplasia and the role of surveillance in light of recent advancements in image-enhanced endoscopy.
- The role of immunonutrition in IBD surgical patients.
- The role of the mesentery in CD.
- Treatment of colorectal cancer and screening strategies in CD/UC patients.
Inflammatory Bowel Disease (IBD) consists of two chronic, immune-mediated conditions affecting the intestine: Crohn's disease (CD) and Ulcerative Colitis (UC). Patients suffering from these conditions often require multi-disciplinary management. In the past 20 years the approach to IBD has changed, mainly with the introduction of new therapeutic agents and the emerging role of surgery. Advances in our understanding of the disease, diagnostic tools and surgical equipment have led to improved treatment outcomes and controversial issues. In the next coming years, efforts will focus on improved peri-operative management, prevention of disease recurrence after surgery, and quality of life improvement.
The aim of this special issue is to summarize advances and controversies in the surgical treatment of Inflammatory Bowel Disease, and to point out areas for further research.
We welcome submissions on the following topics (but are not limited to):
- Advantages and disadvantages of two-stage pouch procedures versus three-stage operations in different clinical scenarios for patients with ulcerative colitis.
- Bariatric surgery in IBD patients.
- Proctologic procedures in IBD patients.
- Surgical management of perianal active Crohn's disease.
- Ileal Pouch Anal Anastomosis in patients with Crohn's disease.
- Novel types of anastomosis (i.e. Kono-S).
- Challenges in managing immunosuppression therapy in steroids dependent patients during the perioperative period, specifically examining if active disease or active immunosuppression has a greater impact on outcomes.
- Need for total proctocolectomy for all UC patients with low-grade dysplasia and the role of surveillance in light of recent advancements in image-enhanced endoscopy.
- The role of immunonutrition in IBD surgical patients.
- The role of the mesentery in CD.
- Treatment of colorectal cancer and screening strategies in CD/UC patients.